ATE308976T1 - Lungensurfactant zubereitungen enthaltendes behandlungset - Google Patents

Lungensurfactant zubereitungen enthaltendes behandlungset

Info

Publication number
ATE308976T1
ATE308976T1 AT99971701T AT99971701T ATE308976T1 AT E308976 T1 ATE308976 T1 AT E308976T1 AT 99971701 T AT99971701 T AT 99971701T AT 99971701 T AT99971701 T AT 99971701T AT E308976 T1 ATE308976 T1 AT E308976T1
Authority
AT
Austria
Prior art keywords
set containing
lung surfactant
treatment set
surfactant preparations
containing lung
Prior art date
Application number
AT99971701T
Other languages
English (en)
Inventor
Paul-Georg Germann
Herbert Rupp
Klaus Eistetter
Ulrich Kilian
Dietrich Haefner
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of ATE308976T1 publication Critical patent/ATE308976T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0082—Lung surfactant, artificial mucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99971701T 1998-11-10 1999-11-09 Lungensurfactant zubereitungen enthaltendes behandlungset ATE308976T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98121324 1998-11-10
PCT/EP1999/008567 WO2000027360A1 (en) 1998-11-10 1999-11-09 Treatment set containing lungsurfactant compositions

Publications (1)

Publication Number Publication Date
ATE308976T1 true ATE308976T1 (de) 2005-11-15

Family

ID=8232946

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99971701T ATE308976T1 (de) 1998-11-10 1999-11-09 Lungensurfactant zubereitungen enthaltendes behandlungset

Country Status (7)

Country Link
EP (1) EP1131055B1 (de)
JP (1) JP2002529394A (de)
AT (1) ATE308976T1 (de)
AU (1) AU1161300A (de)
DE (1) DE69928279T2 (de)
ES (1) ES2253003T3 (de)
WO (1) WO2000027360A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10018022A1 (de) * 2000-04-12 2001-10-31 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant zur Prophylaxe oder Frühbehandlung von akuten Lungenerkrankungen
US20030158087A1 (en) * 2000-04-12 2003-08-21 Dietrich Hafner Novel use of fulmonary surfactant for the prophylaxis or early treatment if acute fulmonary diseases
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
SE0203591D0 (sv) * 2002-12-04 2002-12-04 Siemens Elema Ab Förfarande för beredning av ett mediakament och en medicinsk anordning
WO2004110450A1 (en) * 2003-06-16 2004-12-23 Altana Pharma Ag Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases
AU2004296206A1 (en) * 2003-12-04 2005-06-23 The Scripps Research Institute Treatment and preventions of asthma
EP1781323B1 (de) * 2004-08-06 2010-02-17 Nycomed GmbH Zusammensetzung aus einem pulmonalen surfactant und einem von tnf stammenden peptid
MX2007002903A (es) * 2004-09-10 2007-07-11 Pharmaorigin Aps Metodos para el tratamiento de hemoptisis o hemorragias traqueales, bronquiales o alveolares, locales.
KR20080090442A (ko) * 2006-01-23 2008-10-08 뉴마 인코포레이티드 급성 호흡 곤란 증후군의 치료
EP2049554A4 (de) * 2006-07-20 2011-06-29 Univ Rochester Medical Ct Synthetisches lungensurfaktant und seine verwendung
WO2008057248A2 (en) 2006-10-26 2008-05-15 Next Breath Llc Phospholipid-based inhalation system
ES2625260T5 (es) * 2009-03-26 2020-07-29 Pulmatrix Operating Co Inc Formulaciones de polvo seco y métodos para el tratamiento de enfermedades pulmonares

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6165821A (ja) * 1984-09-07 1986-04-04 Tokyo Tanabe Co Ltd 合成サ−フアクタント及びそれを有効成分とする肺表面活性物質喪失性無気肺の治療剤
JPH05294996A (ja) * 1992-04-17 1993-11-09 Tokyo Tanabe Co Ltd 合成ペプチド、それを含有する肺サーファクタント及び呼吸窮迫症候群治療剤
CZ292186B6 (cs) * 1996-01-24 2003-08-13 Altana Pharma Ag Způsob výroby práškového prostředku s obsahem plicní povrchově aktivní látky, práškový prostředek a jeho použití

Also Published As

Publication number Publication date
ES2253003T3 (es) 2006-05-16
DE69928279D1 (de) 2005-12-15
WO2000027360A1 (en) 2000-05-18
AU1161300A (en) 2000-05-29
EP1131055B1 (de) 2005-11-09
DE69928279T2 (de) 2006-08-17
JP2002529394A (ja) 2002-09-10
EP1131055A1 (de) 2001-09-12

Similar Documents

Publication Publication Date Title
EE03951B1 (et) Inhaleeritav ravimvorm puistetihedusega 0,28 kuni0,38 g/ml, selle valmistamise protsess ja kasutamine
DE69928279D1 (de) Lungensurfactant zubereitungen enthaltendes behandlungset
BG103930A (en) Eletriptan hemisulphate and caffeine containing pharmaceutical compositions
NO20061455L (no) 2,6 dioksopiperidin samt farmasoytiske preparater som inneholder disse
AP1450A (en) Solid oral dosage form comprising a combination of metformin and glibenclamide.
GR3022510T3 (en) Lyospheres comprising gonadotropin
MA21264A1 (fr) Composition permettant d'administrer un medicament sous forme de gellules, d'une poudre ou d'un liquide.
BR0112101A (pt) Interleucina 2 estabilizada
WO1997026919A3 (en) Method of imaging amyloid deposits
ATE286057T1 (de) Pharmazeutische zubereitungen enthaltend clavulansäure
CA2361402A1 (en) Bis-sulfonamides
GB2334446A (en) Aqueous compositions compromising a lipid and a lanolin-derived surfactant,and their use
BR9806895A (pt) Nova formulação; apresentando densidade volumétrica, quanto derramada, de 0,20 a 038 g/ml, compreendendo formoterol
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
ATE245028T1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
NO993407L (no) Fremstilling av proteinpreparater med nedsatt aggregatinnhold
BR9806893A (pt) Nova formulação para inalação; apresentando densidade volumétrica, quando derramada, de 0,20 a 038 g/ml, compreendendo sulfato de terbutalina, processo para preparação da formulação e uso da mesma
AU586988B2 (en) Solid drug formulations and stable suspensions
FI911501A0 (fi) Liposomkomposition foer parenteralt bruk.
WO2003048342A3 (en) Liquid yeast compositions
GEP20043377B (en) Pharmaceutical Complex
MD1473G2 (ro) Remediu antiherpetic
DK0541780T3 (de)
AU3347193A (en) Fungicidal compositions
HUP0002154A3 (en) Use of famotidine for the preparation of pharmaceutical compositions treating depression or symptoms related with depression

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties